A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: listed (1000), planned (748), programmed (540)

UHS register of interests June 2025

Description
Employee Name Aarvold, Dr Alice Beatrice Rachel Aarvold, Dr Alice Beatrice Rachel Adam, Dr Robert Dhugald (Rob) Adam, Dr Robert Dhugald
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/UHS-register-of-interests-June-2025.pdf

Zanubrutinib Ver1

Description
Chemotherapy Protocol LYMPHOMA ZANUBRUTINIB Regimen • Lymphoma - Zanubrutinib Indication Zanubrutinib monotherapy for the treatment of patient
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Zanubrutinib.pdf

Asciminib

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Asciminib Regimen • Asciminib Indication • Patients with chronic phase P
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Asciminib.pdf

Gilteritinib

Description
Chemotherapy Protocol Acute Myeloid Leukaemia GILTERITINIB Regimen  AML - Gilteritinib Indication Gilteritinib for treating relapsed/refractory FLT3 mutation positive myeloid leukaemia in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Gilteritinib.pdf

Pemigatinib

Description
Chemotherapy Protocol CHOLANGIOCARCINOMA PEMIGATINIB Regimen  Cholangiocarcinoma - Pemigatinib Indication Pemigatinib for locally advance
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Pemigatinib.pdf

Guidance for new grant holders_June2022

Description
Guidance for new UHS* grant holders Congratulations, you’ve been awarded some research funding! Now what? What are the key things you need
Url
/Media/Southampton-Clinical-Research/Downloads/Guidance-for-new-grant-holders-June2022.pdf

Nordic 3000

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-CYTARABINE-DOXORUBICIN-PREDNISOLONE-RITUXIMABVINCRISTINE (Nordic 3000) Inpatient-Outpatient Regimen There are multiple versions of this protocol in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Nordic-3000.pdf

Nordic_2000

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-CYTARABINE-DOXORUBICIN-PREDNISOLONE-RITUXIMABVINCRISTINE (Nordic 2000) Inpatient-Outpatient Regimen There are multiple versions of this protocol in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Nordic-2000.pdf

Kadcyla (Trastuzumab emtansine) v1

Description
Chemotherapy Protocol BREAST CANCER KADCYLA (trastuzumab emtansine) Kadcyla (trastuzumab emtansine) is NOT the same drug as Herceptin (trastuzumab). There is considerable
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Kadcyla-Trastuzumab-emtansine-v1.pdf

Bevacizumab (15mgkg)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15) This protocol may require funding Regimen Ovary-Bevaci
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg.pdf
131 to 140 of 450
Previous … 12 13 14 15 16 … Next